Futura Medical PLC FUM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FUM is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- GBX 35.80
- Day Range
- GBX 35.00–36.20
- 52-Week Range
- GBX 23.28–67.00
- Bid/Ask
- GBX 0.00 / GBX 36.20
- Market Cap
- GBX 10.67 Bil
- Volume/Avg
- 241,540 / 949,885
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 34.05
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8
- Website
- https://www.futuramedical.com
Comparables
Valuation
|
Metric
|
FUM
|
ERGO
|
INDV
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 31.20 | 8.37 |
Price/Book Value | 19.70 | 8.19 | — |
Price/Sales | 34.05 | 4.55 | 2.45 |
Price/Cash Flow | — | 35.25 | — |
Price/Earnings
FUM
ERGO
INDV
Financial Strength
|
Metric
|
FUM
|
ERGO
|
INDV
|
|---|---|---|---|
Quick Ratio | 1.46 | 1.72 | 0.68 |
Current Ratio | 1.47 | 1.79 | 0.92 |
Interest Coverage | — | 30.39 | 0.11 |
Quick Ratio
FUM
ERGO
INDV
Profitability
|
Metric
|
FUM
|
ERGO
|
INDV
|
|---|---|---|---|
Return on Assets (Normalized) | −40.96% | 17.36% | 12.41% |
Return on Equity (Normalized) | −64.70% | 28.99% | 620.00% |
Return on Invested Capital (Normalized) | −65.22% | 26.30% | 68.45% |
Return on Assets
FUM
ERGO
INDV
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qkqwnrkvh | Dnkv | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Lwgwbxcp | Rlnbjf | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qzwvvjbp | Tzfsfj | $99.5 Bil | |
MRNA
| Moderna Inc | Xycrjrd | Zlsqv | $38.8 Bil | |
ARGX
| argenx SE ADR | Fphnzxzzc | Jfp | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Mpdnprd | Lry | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Jmnqxsznt | Dkmdhtk | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Khwfslnb | Sxqrft | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Kgyckxhyth | Wszvpy | $12.5 Bil | |
INCY
| Incyte Corp | Npzgljg | Zjwzrr | $11.6 Bil |